Replies to post #135251 on Anavex Life Sciences Corp (AVXL)

[LakeshoreLeo1953]

IF you were me, and thought you tried to know the things you could know...

How does your assumption in May 2017 that derivative data "analysis"
would allow that selective criteria to be known mid Summer and January would be the fudge factor for CRO enlistment.....make a good or bad
options gamble?

I agree with your premise, but have resigned myself to making money
in the stock by timing re entry rather than guessing at Management's
transparency in the design process.

Just a better bet for me.

[nidan7500]

investor...BINGO..."fool me once" ...new moto for M..

Instead the company is working hard to be as confident as can be that data analysis conclusion are valid and the optimum inclusion/exclusion criteria are set for the trials. Better to wait a bit and optimise for success than to go too early and fail

[bas2020]

More on ACTC...

https://alzheimersnewstoday.com/2017/12/19/top-alzheimers-scientists-forming-consortium-to-improve-trials-of-alzheimers-therapies/

“This nationwide collaboration will move us closer toward techniques to prevent Alzheimer’s disease,” Aisen said.

“Perhaps one day we’ll be able to do a blood draw to identify individuals in need of preventive measures to stave off dementia and Alzheimer’s disease. We’re not there yet, but we’ve had many promising studies that have provided bread crumbs on how to get there.”

Seems he knows something...